<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04389060</url>
  </required_header>
  <id_info>
    <org_study_id>081-1819-EXP</org_study_id>
    <nct_id>NCT04389060</nct_id>
  </id_info>
  <brief_title>Effect of Acute Dietary Supplementation With Grape Seed Extract on Aortic Stiffness, Arterial Pressure, and Blood Vessel Dilation in Collegiate Obese Individuals at Rest</brief_title>
  <official_title>Effects of Acute Grape Seed Extract Supplementation on Hemodynamics in Obese Males</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>California Baptist University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>California Baptist University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigated if elevated BP and aortic stiffness characterized in obese
      individuals are attenuated following acute grape seed extract supplementation. It is
      hypothesized that acute dietary supplementation with grape seed extract attenuates aortic
      stiffness, systolic blood pressure, diastolic blood pressure, mean arterial pressure, and
      total peripheral resistance and these effects are partially due to reductions in peripheral
      vasoconstriction
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty men (obese = 10; normal body weight (NBW) = 10) participated in this study. Effects of
      placebo (PL: 600 mg) and GSE (600 mg) on systolic blood pressure (SBP), diastolic blood
      pressure (DBP), mean arterial pressure (MAP), heart rate (HR), stroke volume (SV), cardiac
      output (Q), total peripheral resistance (TPR), and AoS were compared 2 h after ingestion of
      GSE or PL on different days, one week apart. Arterial blood pressure was measured using a
      sphygmomanometer from a brachial artery at the level of the heart on chair. HR and SV were
      continuously measured using a non-invasive device (Physio Flow). CO was calculated by HR X
      SV. TPR was calculated by MAP/CO.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Actual">March 1, 2020</completion_date>
  <primary_completion_date type="Actual">March 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Double blind, cross-over design</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>change in heart rate</measure>
    <time_frame>2 hours after each supplementation</time_frame>
    <description>beats per minute</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in stroke volume</measure>
    <time_frame>2 hours after each supplementation</time_frame>
    <description>volume per stroke</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in cardiac output</measure>
    <time_frame>2 hours after each supplementation</time_frame>
    <description>total volume for a minute</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in systolic blood pressure</measure>
    <time_frame>2 hours after each supplementation</time_frame>
    <description>pressure exerted during contraction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in diastolic blood pressure</measure>
    <time_frame>2 hours after each supplementation</time_frame>
    <description>pressure exerted during relaxation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in mean arterial pressure</measure>
    <time_frame>2 hours after each supplementation</time_frame>
    <description>One reported pressure (systolic blood pressure-diastolic blood pressure)/3 + diastolic blood pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in total peripheral resistance</measure>
    <time_frame>2 hours after each supplementation</time_frame>
    <description>One reported value (mean arterial pressure/cardiac output)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>GSE group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects took a single dose of 600 mg GSE in capsule form through ingestion 2 hours prior to testing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects took a single dose of 600 mg starch in capsule form through ingestion 2 hours prior to testing</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Grape seed extract</intervention_name>
    <description>Two capsule grape seed extract (total 600 mg)</description>
    <arm_group_label>GSE group</arm_group_label>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Obesity: body mass index (&gt;30), Normal body weight: body mass index (25-29)

        Exclusion Criteria:

          -  cardiovascular diseases or consume any antihypertensive medication or supplementation
             that can affect blood pressure or aortic stiffness
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>29 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>California Baptist University</name>
      <address>
        <city>Riverside</city>
        <state>California</state>
        <zip>92504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 8, 2020</study_first_submitted>
  <study_first_submitted_qc>May 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2020</study_first_posted>
  <last_update_submitted>May 11, 2020</last_update_submitted>
  <last_update_submitted_qc>May 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>California Baptist University</investigator_affiliation>
    <investigator_full_name>Jong-Kyung Kim</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Grape Seed Extract</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

